HUMACYTE INC (HUMA) Stock Earnings & Estimates
USA - NASDAQ:HUMA - US44486Q1031 - Common Stock
1.64 USD
-0.05 (-2.96%)
1.67 USD
+0.03 (+1.83%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.49M -75.93% | 1.26M -15.44% | 1.57M 24.60% | 58.283K -100.00% | 218.576K | 3.665M | 65.476M 1,686.52% | 95.843M 46.38% | 406.12M 323.73% | 615.78M 51.63% | 1.062B 72.46% | 2.716B 155.74% | 3.539B 30.30% | |
| EBITDA YoY % growth | -56.25M 28.74% | -72.96M -29.71% | -76.37M -4.67% | -98.634M -20.90% | -83.232M -15.69% | -60.486M 43.37% | 714K 101.18% | 12.75M 1,685.71% | 68.952M 440.80% | 130.25M 88.90% | 212.47M 63.12% | 308.04M 44.98% | N/A | |
| EBIT YoY % growth | -64.6M 24.61% | -81.2M -25.70% | -84.58M -4.16% | -100.904M -18.29% | -118.406M -13.95% | -102.203M 10.35% | -44.201M 56.75% | -63.479M -43.61% | 280.82M 542.38% | 474.59M 69.00% | 707.62M 49.10% | 1.841B 160.17% | 2.523B 37.05% | |
| Operating Margin | -4,335.57% | -6,444.44% | -5,387.26% | -173,128.65% | -54,171.38% | -2,788.63% | -67.51% | -66.23% | 69.15% | 77.07% | 66.63% | 67.78% | 71.29% | |
| EPS YoY % growth | N/A | -0.51 | -0.13 74.51% | -1.08 -723.08% | -1.38 -17.76% | -0.31 75.23% | -0.30 3.05% | 0.26 186.80% | 3.84 1,360.19% | 5.28 37.77% | 7.17 35.71% | 13.06 82.08% | 16.43 25.86% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 51.06% | -0.15 4.38% | -0.15 -152.82% | -0.14 40.50% | -0.11 28.95% | -0.09 38.33% | -0.05 65.52% | -0.02 85.71% | 0.02 117.78% | 0.05 154.05% |
| Revenue Q2Q % growth | 940.777K | 2.165M | 4.526M 775.44% | 6.597M 2,091.69% | 9.902M 952.53% | 12.87M 494.46% | 25.704M 467.92% | 34.272M 419.51% | 43.248M 336.76% | 52.938M 311.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.76M 18.10% | -23.382M 16.49% | -19.602M 15.45% | -18.39M 38.14% | -16.858M 31.91% | -14.674M 37.24% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.24 50.00% | -0.16 | -0.08 | -45.54% |
| Q1 2025 Q2Q % growth | 0.28 196.55% | -0.19 | 0.47 | 244.48% |
| Q4 2024 Q2Q % growth | -0.16 33.33% | -0.26 | 0.10 | 37.25% |
| Q3 2024 Q2Q % growth | -0.33 -32.00% | -0.25 | -0.08 | -30.16% |
| Q2 2024 Q2Q % growth | -0.48 -118.18% | -0.24 | -0.24 | -97.73% |
| Q1 2024 Q2Q % growth | -0.29 19.44% | -0.23 | -0.06 | -26.36% |
| Q4 2023 Q2Q % growth | -0.24 -500.00% | -0.25 | 0.01 | 3.91% |
| Q3 2023 Q2Q % growth | -0.25 | -0.26 | 0.01 | 3.25% |
| Q2 2023 Q2Q % growth | -0.22 -162.86% | -0.22 | 0.00 | 1.81% |
| Q1 2023 Q2Q % growth | -0.36 -89.47% | -0.21 | -0.15 | -68.39% |
| Q4 2022 Q2Q % growth | -0.04 -109.76% | -0.24 | 0.20 | 83.31% |
| Q3 2022 Q2Q % growth | -0.25 65.28% | -0.22 | -0.03 | -14.00% |
| Q2 2022 Q2Q % growth | 0.35 | -0.22 | 0.57 | 257.16% |
| Q1 2022 Q2Q % growth | -0.19 5.00% | -0.21 | 0.02 | 9.87% |
| Q4 2021 Q2Q % growth | 0.41 | -0.21 | 0.62 | 296.08% |
| Q3 2021 Q2Q % growth | -0.72 | -0.21 | -0.51 | -243.78% |
| Q2 2021 Q2Q % growth | 0.00 | -0.58 | 0.58 | 100.00% |
| Q1 2021 Q2Q % growth | -0.20 | -0.92 | 0.72 | 78.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 301K | 1.023M | -722K | -70.58% |
| Q1 2025 Q2Q % growth | 517K | 775.537K | -258.537K | -33.34% |
| Q4 2024 Q2Q % growth | 218.576K | -218.576K | -100.00% | |
| Q4 2023 Q2Q % growth | 58.283K | -58.283K | -100.00% | |
| Q3 2023 Q2Q % growth | -100.00% | 68.003K | -68.003K | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | 68.003K | -68.003K | -100.00% |
| Q1 2023 Q2Q % growth | -100.00% | 168.912K | -168.912K | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | 200.093K | -200.093K | -100.00% |
| Q3 2022 Q2Q % growth | 30K -87.50% | 207.57K | -177.57K | -85.55% |
| Q2 2022 Q2Q % growth | 1.3M 88.41% | 208.59K | 1.091M | 523.23% |
| Q1 2022 Q2Q % growth | 230K 43.75% | 250.308K | -20.308K | -8.11% |
| Q4 2021 Q2Q % growth | 180K 50.00% | 259.08K | -79.08K | -30.52% |
| Q3 2021 Q2Q % growth | 240K -73.63% | 379.103K | -139.103K | -36.69% |
| Q2 2021 Q2Q % growth | 690K | 102K | 588K | 576.47% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.55% | -23.39% | 3.95% |
| Revenue | 0% | -60.55% | -43.93% | -55.03% |